Technical Analysis for PHAT - Phathom Pharmaceuticals, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 9.12 | 0.66% | 0.06 |
PHAT closed up 0.66 percent on Wednesday, April 24, 2024, on 47 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 8
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Up 3 Days in a Row | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Stochastic Buy Signal | Bullish | 0.66% | |
| Narrow Range Bar | Range Contraction | 0.66% | |
| Wide Bands | Range Expansion | 0.66% | |
| Oversold Stochastic | Weakness | 0.66% | |
| MACD Bearish Centerline Cross | Bearish | 1.22% |
| Alert | Time |
|---|---|
| Possible NR7 | about 5 hours ago |
| Rose Above Previous Day's High | about 9 hours ago |
| Up 2% | about 9 hours ago |
| Up 1% | about 9 hours ago |
| Possible NR7 | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/08/2024
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development and commercialization of novel treatments for gastrointestinal diseases and disorders. It develops Vonoprazan, a potassium-competitive acid blocker. The company was founded by Tadataka Yamada, David Socks, Azmi Nabulsi, Aditya Kohli, and Roger Ulrich on January 9, 2018 and is headquartered in Buffalo Grove, IL.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Acid Natural Sciences Medication Gastrointestinal Disorders Potassium Gastrointestinal Disease Tadataka Yamada
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Acid Natural Sciences Medication Gastrointestinal Disorders Potassium Gastrointestinal Disease Tadataka Yamada
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 17.0 |
| 52 Week Low | 6.065 |
| Average Volume | 946,011 |
| 200-Day Moving Average | 10.20 |
| 50-Day Moving Average | 9.67 |
| 20-Day Moving Average | 10.24 |
| 10-Day Moving Average | 9.61 |
| Average True Range | 0.74 |
| RSI (14) | 42.53 |
| ADX | 20.06 |
| +DI | 18.83 |
| -DI | 22.50 |
| Chandelier Exit (Long, 3 ATRs) | 10.06 |
| Chandelier Exit (Short, 3 ATRs) | 11.04 |
| Upper Bollinger Bands | 11.99 |
| Lower Bollinger Band | 8.49 |
| Percent B (%b) | 0.18 |
| BandWidth | 34.24 |
| MACD Line | -0.14 |
| MACD Signal Line | 0.11 |
| MACD Histogram | -0.25 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.54 | ||||
| Resistance 3 (R3) | 9.56 | 9.44 | 9.47 | ||
| Resistance 2 (R2) | 9.44 | 9.33 | 9.43 | 9.45 | |
| Resistance 1 (R1) | 9.28 | 9.27 | 9.36 | 9.26 | 9.42 |
| Pivot Point | 9.16 | 9.16 | 9.20 | 9.15 | 9.16 |
| Support 1 (S1) | 9.00 | 9.05 | 9.08 | 8.98 | 8.82 |
| Support 2 (S2) | 8.88 | 8.99 | 8.87 | 8.79 | |
| Support 3 (S3) | 8.72 | 8.88 | 8.77 | ||
| Support 4 (S4) | 8.70 |
